deltatrials
Completed NA INTERVENTIONAL 1-arm NCT02030938

SERI® Surgical Scaffold for Soft Tissue Support in Revision Augmentation Surgery

Sponsor: Sofregen Medical, Inc.

Conditions Subjects Requiring Revision Breast Augmentation Surgery
Interventions SERI® Surgical Scaffold
Updated 9 times since 2017 Last updated: Nov 29, 2021 Started: Dec 31, 2013 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Subjects Requiring Revision Breast Augmentation Surgery, this trial is completed. The trial is conducted by Sofregen Medical, Inc. and has accumulated 9 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jul 2017 · 5 months · monthly snapshotCompleted~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshotCompleted~Jan 2022 – ~Jul 2024 · 30 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2022 — Jul 2024 [monthly]

    Completed NA

  5. Jan 2021 — Jan 2022 [monthly]

    Completed NA

▶ Show 4 earlier versions

  1. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  2. Jul 2017 — Jun 2018 [monthly]

    Completed NA

  3. Feb 2017 — Jul 2017 [monthly]

    Completed NA

  4. Jan 2017 — Feb 2017 [monthly]

    Completed NA

    First recorded

Dec 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sofregen Medical, Inc.
Data source: Sofregen Medical, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations